Dosage form development, manufacture, and stability studies of PTH-IA
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
The University Of Iowa UEI Z1H9VJS8NG16
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $611,305
Award facts
- Opportunity
-
- CRO Support for NCATS Drug Product Development, Manufacture, and Stability Studies Pre-Solicitation · 75N95020R00027 · Posted Jul 21, 2016
- Contract value 100% obligated
- $611,304.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Iowa City, IA 52242, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $28,468 | |
| Supplemental Agreement for work within scope | $109,219 | |
| Supplemental Agreement for work within scope | $122,435 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $351,183 |
About this award
The U.S. National Center for Advancing Translational Sciences (NCATS) awarded a $611,304.67 firm fixed-price delivery order contract to The University of Iowa for "DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF PTH-IA". This contract is a task order under the NCATS Drug Product Development Studies 2017-2022 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no set-aside designation and will be performed in Iowa City, Iowa with a completion date of June 30, 2025. The University of Iowa is a major public research university that has extensive experience supporting federal agencies through contracts and grants, particularly in the areas of medical research, healthcare services, and specialized laboratory testing.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to The University Of Iowa by National Institute on Drug Abuse (National Institutes of Health) on September 28, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $611,305 on 75N95020F00001.
Which agency awarded contract 75N95020F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under HHSN271201700019I, an indefinite delivery contract, on NCATS Drug Product Development Studies 2017-2022.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award